In this discussion, Adrian Parry-Jones, PhD, MRCP, of The University of Manchester in the United Kingdom, details how the use of direct oral anticoagulants (DOACs) have overtaken previously administered treatments, thus making DOAC reversal a rapidly advancing modality for combating bleeding events.